Literature DB >> 34458444

In vitro Assessment of RNA Polymerase I Activity.

Marzia Govoni1.   

Abstract

In eukaryotic cells transcriptional processes are carried out by three different RNA polymerases: RNA polymerase I which specifically transcribes ribosomal RNA (rRNA), RNA polymerase II which transcribes protein-coding genes to yield messenger RNAs (mRNAs) and small RNAs, while RNA polymerase III transcribes the genes for transfer RNAs and for the smallest species of ribosomal RNA (5S rRNA). This protocol describes an in vitro assay to evaluate the rRNA transcriptional activity of RNA polymerase I. The method measures the quantity of radiolabelled uridine 5' triphosphate incorporated in ex novo synthesized rRNA molecules by RNA polymerase I, in optimal conditions for the enzyme activity and in the presence of a toxin, α-amanitin, which inhibits RNA polymerase II and III without affecting RNA polymerase I (Novello and Stirpe, 1970).
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Nuclei isolation; RNA polymerase I; Radiolabelled uridine incorporation; Ribosomal RNA transcription; α-amanitin

Year:  2017        PMID: 34458444      PMCID: PMC8376601          DOI: 10.21769/BioProtoc.2120

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  6 in total

1.  Simultaneous assay of RNA polymerase I and II in nuclei isolated from resting and growing rat liver with the use of alpha-amanitin.

Authors:  F Novello; F Stirpe
Journal:  FEBS Lett       Date:  1970-05-11       Impact factor: 4.124

2.  Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells.

Authors:  Massimo Derenzini; Lorenzo Montanaro; Alessandra Chillà; Elena Tosti; Manuela Vici; Stefania Barbieri; Marzia Govoni; Giuliano Mazzini; Davide Treré
Journal:  J Cell Physiol       Date:  2005-02       Impact factor: 6.384

Review 3.  Recent developments in the measurement of nucleic acids in biological materials. A supplementary review.

Authors:  H N Munro; A Fleck
Journal:  Analyst       Date:  1966-02       Impact factor: 4.616

4.  Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.

Authors:  F Scala; E Brighenti; M Govoni; E Imbrogno; F Fornari; D Treré; L Montanaro; M Derenzini
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

5.  The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells.

Authors:  G Donati; S Bertoni; E Brighenti; M Vici; D Treré; S Volarevic; L Montanaro; M Derenzini
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

6.  The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective.

Authors:  Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Onco Targets Ther       Date:  2013-07-19       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.